New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination

Mostrar otras versiones (1)

BACKGROUND: India had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01(E) and BCG-revaccination have recently completed phase IIb trials and estimates of their population-level impact ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Rebecca A., Weerasuriya, Chathika K., Portnoy, Allison, Mukandavire, Christinah, Quaife, Matthew, Bakker, Roel, Scarponi, Danny, Harris, Rebecca C., Rade, Kirankumar, Mattoo, Sanjay Kumar, Tumu, Dheeraj, Menzies, Nicolas A., White, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403932/
https://www.ncbi.nlm.nih.gov/pubmed/37542319
http://dx.doi.org/10.1186/s12916-023-02992-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403932/
https://www.ncbi.nlm.nih.gov/pubmed/37542319
http://dx.doi.org/10.1186/s12916-023-02992-7

Ejemplares similares